VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $76,107,000 | +46.2% | 3,272,104 | 0.0% | 0.03% | +36.8% |
| Q1 2018 | $52,058,000 | +74.9% | 3,272,104 | +129.5% | 0.02% | +72.7% |
| Q4 2017 | $29,761,000 | +45.9% | 1,425,568 | 0.0% | 0.01% | +37.5% |
| Q3 2017 | $20,392,000 | -28.4% | 1,425,568 | -13.2% | 0.01% | -27.3% |
| Q2 2017 | $28,488,000 | +47.8% | 1,642,543 | -6.1% | 0.01% | +37.5% |
| Q1 2017 | $19,276,000 | -50.9% | 1,749,502 | -35.3% | 0.01% | -52.9% |
| Q4 2016 | $39,286,000 | -37.2% | 2,705,853 | +1.3% | 0.02% | -43.3% |
| Q3 2016 | $62,531,000 | +33.6% | 2,670,102 | +14.6% | 0.03% | +36.4% |
| Q2 2016 | $46,821,000 | -26.1% | 2,329,177 | -3.3% | 0.02% | -29.0% |
| Q1 2016 | $63,395,000 | -76.1% | 2,409,330 | -7.8% | 0.03% | -76.5% |
| Q4 2015 | $264,897,000 | -42.6% | 2,612,211 | +0.8% | 0.13% | -45.5% |
| Q3 2015 | $461,172,000 | -14.8% | 2,590,734 | +6.2% | 0.24% | -10.7% |
| Q2 2015 | $541,513,000 | +8.7% | 2,438,778 | -3.0% | 0.27% | +11.1% |
| Q1 2015 | $498,010,000 | +37.0% | 2,513,679 | -0.9% | 0.24% | +31.9% |
| Q4 2014 | $363,488,000 | +11.4% | 2,535,500 | +2.0% | 0.18% | +4.5% |
| Q3 2014 | $326,279,000 | -48.6% | 2,485,824 | -50.5% | 0.18% | +3.5% |
| Q2 2014 | $635,278,000 | +93.5% | 5,025,820 | +101.8% | 0.17% | -7.6% |
| Q1 2014 | $328,308,000 | +19.6% | 2,490,956 | +6.4% | 0.18% | +17.1% |
| Q4 2013 | $274,610,000 | +18.0% | 2,340,127 | +5.0% | 0.16% | +16.2% |
| Q3 2013 | $232,690,000 | +17.7% | 2,228,892 | -3.0% | 0.14% | +10.6% |
| Q2 2013 | $197,658,000 | +13.5% | 2,297,702 | -1.0% | 0.12% | +8.8% |
| Q1 2013 | $174,188,000 | -31.9% | 2,321,276 | -52.2% | 0.11% | -34.3% |
| Q3 2012 | $255,774,000 | +123.6% | 4,857,810 | +102.3% | 0.17% | +87.0% |
| Q2 2012 | $114,369,000 | – | 2,401,648 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |